The Joint Corp. (JYNT) 10-Q 22 Dec 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Dec. 10, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	JOINT Corp
Document Type	10-Q
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		9,723,933
Amendment Flag	FALSE
Entity Central Index Key	1612630
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	30-Sep-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Cash	$2,373,925	$3,516,750
Restricted cash	217,736	58,786
Accounts receivable, net	333,156	394,655
Income taxes receivable	320,290
Note receivable - current portion	27,119	25,929
Deferred franchise costs - current portion	957,950	939,750
Deferred tax asset - current portion	701,200	701,200
Deferred offering costs	511,921
Prepaid expenses and other current assets	68,959	23,729
Total current assets	5,512,256	5,660,799
Property and equipment, net	794,383	400,267
Note receivable	38,778	59,269
Note receivable - related party, net of allowance		21,750
Deferred franchise costs, net of current portion	2,086,800	2,283,000
Deferred tax asset - noncurrent	1,265,700	1,265,700
Deposits and other assets	77,650	77,650
Total assets	9,775,567	9,768,435
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable and accrued expenses	677,272	226,757
Co-op funds liability	99,104	54,133
Payroll liabilities	316,529	128,370
Advertising fund deferred revenue	118,632	4,652
Income taxes payable		419,297
Deferred rent - current portion	72,417
Deferred revenue - current portion	2,704,250	2,756,250
Total current liabilities	3,988,204	3,589,459
Deferred rent, net of current portion	471,146
Deferred revenue, net of current portion	6,754,750	7,252,084
Other liabilities	204,300	147,753
Total liabilities	11,418,400	10,989,296
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 25,000 issued and outstanding, aggregate liquidation preference of $1,000,000	25	25
Common stock, $0.001 par value; 20,000,000 shares authorized, 5,365,055 shares issued and 4,831,055 shares outstanding as of September 30, 2014 and 5,340,000 shares issued and 4,806,000 outstanding as of December 31, 2013	5,365	5,340
Additional paid-in capital	1,588,395	1,546,373
Treasury stock (534,000 shares, at cost)	-791,638	-791,638
Accumulated deficit	-2,444,980	-1,980,961
Total stockholders' deficit	-1,642,833	-1,220,861
Total liabilties and stockholders' deficit	$9,775,567	$9,768,435

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Series A preferred stock, par value (in Dollars per share)	$0.00	$0.00
Series A preferred stock, shares authorized	50,000	50,000
Series A preferred stock, shares issued	25,000	25,000
Series A Preferred stock, shares outstanding	25,000	25,000
Series A preferred stock, liquidation preference (in Dollars)	$1,000,000	$1,000,000
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	5,365,055	5,340,000
Common stock, shares outstanding	4,831,055	4,806,000
Treasury stock, shares	534,000	534,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues:
Royalty fees	$871,462	$437,323	$2,233,053	$1,011,223
Franchise fees	435,000	570,500	1,469,500	1,956,333
Regional developer fees	152,250	164,500	377,000	536,250
IT related income and software fees	218,400	192,550	629,225	552,975
Advertising fund revenue	88,031	61,876	204,141	143,100
Other income	51,452	46,027	148,347	105,707
Total revenues	1,816,595	1,472,776	5,061,266	4,305,588
Cost of revenues:
Franchise cost of revenues	556,495	433,513	1,505,569	1,307,614
IT cost of revenues	29,324	53,242	164,987	185,870
Total cost of revenues	585,819	486,755	1,670,556	1,493,484
Selling and marketing expenses	324,177	141,212	723,955	603,490
Depreciation and amortization	52,823	19,142	141,707	50,656
General and administrative expenses	1,164,601	631,932	3,215,242	1,859,538
Total selling, general and administrative expenses	1,541,601	792,286	4,080,904	2,513,684
Income (loss) from operations	-310,825	193,735	-690,194	298,420
Other expense	-54,599	-5,000	-58,399	-27,000
Income (loss) before income tax (provision) benefit	-365,424	188,735	-748,593	271,420
Income tax (provision) benefit	163,051	-146,188	284,574	-115,521
Net income (loss)	($202,373)	$42,547	($464,019)	$155,899
Weighted average shares outstanding:
Basic earnings (loss) per share (in Dollars per share)	($0.04)	$0.01	($0.10)	$0.03
Diluted earnings (loss) per share (in Dollars per share)	($0.04)	$0.01	($0.10)	$0.02

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net (loss) income	($464,019)	$155,899
Provision for bad debts	91,831
Depreciation and amortization	141,707	50,656
Deferred income taxes		185,688
Accrued interest on notes receivable		945
Stock based compensation expense	42,047
Changes in operating assets and liabilties:
Restricted cash	-158,950	-14,389
Accounts receivable	-8,582	-143,060
Income taxes receivable	-320,290
Prepaid income taxes		-100,572
Prepaid expenses and other current assets	-45,230	31,459
Deferred franchise costs	178,000	-180,250
Deposits and other assets		-70,578
Accounts payable and accrued expenses	450,515	83,480
Co-op funds liability	44,971	45,691
Payroll liabilities	188,159	13,946
Advertising fund deferred revenue	113,980	-31,302
Other liabilities	56,547	46,289
Deferred rent	543,563	-3,579
Income taxes payable	-419,297
Deferred revenue	-549,334	450,667
Net cash (used in) provided by operating activities	-114,382	520,990
Cash flows from investing activities:
Purchase of property and equipment	-538,323	-135,627
Proceeds from sale of equipment	2,500
Payments received on notes receivable	19,301	477
Net cash used in investing activities	-516,522	-135,150
Cash flows from financing activities:
Deferred offering costs	-511,921
Net cash used in financing activities	-511,921
Net (decrease) increase in cash	-1,142,825	385,840
Cash at beginning of period	3,516,750	3,565,592
Cash at end of period	2,373,925	3,951,432
Supplemental cash flow disclosures:
Cash paid for income taxes	$420,250

Note_1_Nature_of_Operations_an

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 1:      Nature of Operations and Summary of Significant Accounting Policies
	Basis of Presentation
	These unaudited financial statements represent the condensed consolidated financial statements of The Joint Corp. and its wholly owned subsidiary The Joint Corporate Unit No. 1, LLC (collectively, the “Company”). These unaudited condensed consolidated financial statements should be read in conjunction with The Joint Corp. and Subsidiary consolidated financial statements and the notes thereto as set forth in The Joint Corp.’s Form S-1, which included all disclosures required by generally accepted accounting principles. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company on a consolidated basis and the consolidated results of operations and cash flows for the interim periods presented. The results of operations for the periods ended September 30, 2014 and 2013 are not necessarily indicative of expected operating results for the full year. The information presented throughout the document as of and for the periods ended September 30, 2014 and 2013 is unaudited.
	Nature of Operations
	The Joint Corp. (“The Joint”), a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising chiropractic clinics, selling regional developer rights and supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.
	The Joint Corporate Unit No. 1, LLC (the “Clinic”), an Arizona limited liability company, was formed on July 14, 2010 for the purpose of operating chiropractic centers in the state of Arizona. The assets of the Clinic were sold on July 1, 2012, and all remaining account balances were consolidated with The Joint as of December 31, 2012.
	We completed our initial public offering of 3,000,000 shares of common stock at an initial price to the public of $6.50 per share on November 14, 2014, whereupon we received aggregate net proceeds of approximately $17,285,000 after deducting underwriting discounts, commissions and other offering expenses. Our underwriters exercised their option to purchase 450,000 additional shares of common stock to cover over-allotments on November 18, 2014, pursuant to which we received aggregate net proceeds of approximately $2,710,000, after deducting underwriting discounts, commissions and expenses.  Also, in conjunction with the IPO, we issued warrants to the underwriters for the purchase of 90,000 shares of common stock, which can be exercised between November 10, 2015 and November 10, 2018 at an exercise price of $8.125 per share.
	The following table summarizes the number of clinics in operation under franchise agreements for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Clinics open at beginning of period		215			130		175			82
	Clinics opened during the period		16			24		57			74
	Clinics closed during the period		(1	)		-		(2	)		(2	)
	Clinics in operation at the end of the period		230			154		230			154
	Clinics sold but not yet operational							248			254
	Concentrations of Credit Risk
	We grant credit in the normal course of business to franchisees related to the collection of initial franchise fees, royalties, and other operating revenues. We periodically perform credit analysis and monitor the financial condition of the franchisees to reduce credit risk. As of September 30, 2014 and December 31, 2013, two franchisees represented 31% of outstanding accounts receivable. We did not have any customers that represented greater than 10% of our revenues during the three and nine months ended September 30, 2014 and 2013.
	Accounts Receivable
	Accounts receivable represent amounts due from franchisees for royalties and marketing and advertising fees and contributions. We consider a reserve for doubtful accounts based on the creditworthiness of our franchisees. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is our best estimate of uncollectible amounts and is determined based on specific identification and historical performance we track on an ongoing basis. Losses could differ materially from amounts estimated in determining the allowance. We determined that an allowance for doubtful accounts was not necessary at December 31, 2013. As of September 30, 2014, we had allowance for doubtful accounts of $70,081.
	Long-Lived Assets
	We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to undiscounted future cash flows in our assessment of whether or not long-lived assets have been impaired. No impairments of long-lived assets were recorded for the periods ended September 30, 2014 and 2013.
	Advertising Fund
	We have established an advertising fund for national marketing and advertising of services offered by the clinics owned by the franchisees. As stipulated in the typical franchise agreement, a franchisee, in addition to the monthly royalty fee, pays a monthly marketing fee of 1% of gross sales, which may increase to 2% at our discretion. We segregate the marketing funds collected and use the funds for specific purposes as outlined in our franchise disclosure document. As amounts are expended from the fund, we recognize advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on our condensed consolidated balance sheets.
	Co-Op Marketing Funds
	Franchisees have established regional co-ops for advertising within their local and regional markets. The Joint maintains an agency relationship under which the marketing funds collected are segregated and used for the specified purposes as directed by the co-ops officers. The marketing funds are included in restricted cash on our condensed consolidated balance sheets.
	Revenue Recognition
	We generate revenue through initial franchise fees, regional developer fees, transfer fees, royalties, IT related income, and computer software fees.
	Initial Franchise Fees. We require the entire non-refundable initial franchise fee to be paid upon execution of the franchise agreement. Initial franchise fees received from a franchisee are recognized as revenue when we have performed substantially all initial services required by the franchise agreement, which generally is considered to be upon the opening of each franchised clinic.  Franchise agreements have an initial term of ten years.  The franchisor’s services under the franchise agreement include: training of franchisee and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees or guarantees on their behalf.
	Regional Developer Fees. During 2011, we established a regional developer program to bring on independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee of 25% of the then current franchise fee for each franchise they receive the right to develop within a specified geographical region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive 50% of franchise fees collected upon the sale of franchises within their region, and a royalty of 3% of sales generated by franchised clinics in their region. Regional developer fees are non-refundable and are recognized as revenue when we have performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Upon the execution of a regional developer agreement, we estimate the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. When we anticipate that the number of franchised clinics to be opened will exceed the contracted minimum, the license fee on a per-clinic basis is determined by dividing the total fee collected from the regional developer by the number of clinics expected to be opened within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. We reassess the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the fee per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the remaining unopened franchised clinics within the region. The franchisor’s services under regional developer agreements include site selection, grand opening support for two clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of our regional developer agreements grant us the option to repurchase the regional developer’s license.
	Royalties.  We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales and a marketing and advertising fee of 1% of gross sales. Certain franchisees with franchise agreements acquired during our formation pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales period has ended. We consider a reserve for doubtful accounts based on the creditworthiness of the franchisee. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that we track on an ongoing basis.
	IT Related Income and Software Fees.  We collect a monthly computer software fee for use of our proprietary chiropractic software, computer support, and internet services support, which was rolled out to all the clinics in April 2012. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase the clinics’ computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue upon receipt of equipment by the franchisee.
	Advertising Costs
	Our policy is to expense all operating advertising costs as incurred. Advertising expenses were $53,691 and $104,320 for three months ended September 30, 2014 and 2013, respectively, and $93,730 and $238,529 for the nine months ended September 30, 2014 and 2013, respectively.
	Selling, General and Administrative Costs
	General and administrative costs. General and administrative costs include all corporate and administrative functions that support our clinics and provide an infrastructure to facilitate our operations and future growth. Components of these costs include executive management, supervisory and staff salaries, bonuses and related taxes and employee benefits, marketing, travel, information systems, training, support center rent and related occupancy costs, and professional and consulting fees.
	Selling and marketing expenses. Selling and marketing expenses consist principally of advertising and promotion, outside services, media and advertising, marketing fund expenditures and internal software costs. These costs are directed through our chief marketing officer and are paid for with the 1.0% marketing fee we collect from franchisees. Outside services and costs includes programs to create brand awareness and promotion in new markets for potential clinic locations. All advertising costs are expensed as incurred.
	Depreciation and amortization. Depreciation and amortization is computed using the straight line method over the estimated useful lives of any property and equipment.
	Income Taxes
	We account for income taxes in accordance with the Accounting Standards Codification that requires the recognition of deferred income taxes for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.
	At September 30, 2014 and December 31, 2013, we maintained a liability for income taxes for uncertain tax positions of approximately $204,000 and $148,000, respectively, of which $50,000 and $33,000 respectively, represent penalties and interest and are recorded in the  “other liabilities” section of the accompanying condensed consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Our tax returns for tax years subject to examination by tax authorities include 2011 through the current period for state and federal reporting purposes.
	Earnings (Loss) per Common Share
	Basic earnings (loss) per common share includes no dilution and is computed by dividing the earnings (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options. The impact of all potentially dilutive securities outstanding was anti-dilutive for the three and nine months ended September 30, 2014, as a net loss was incurred for these periods.
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Net income (loss)	$	(202,373	)	$	42,547	$	(464,019	)	$	155,899
	Weighted average common shares outstanding - basic		4,828,122			5,340,000		4,819,861			5,340,000
	Effect of dilutive preferred shares		-			1,335,000		-			1,335,000
	Weighted average common shares outstanding - diluted		4,828,122			6,675,000		4,819,861			6,675,000
	Basic earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.03
	Diluted earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.02
	Securities outstanding at September 30, 2014 which could be dilutive in future periods, some of which are included in the periods presented, include preferred stock convertible into 1,335,000 shares of common stock issued in 2010, options to purchase 534,000 shares of common stock issued in 2013 in connection with the purchase of treasury stock, options to purchase 268,335 shares of common stock and 542,352 shares of unvested restricted stock issued as compensation in 2014.
	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs and the related deferred tax assets and liabilities as long-term or current, uncertain tax positions and realizability of deferred tax assets.
	Recent Accounting Pronouncements
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle, and in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our condensed consolidated financial statements.

Note_2_Notes_Receivable

Note 2 - Notes Receivable	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 2:      Notes Receivable
	Effective July 2012, we sold our company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a $90,000 unsecured promissory note. The note bears interest at 6% per annum for fifty-four months and requires monthly principal and interest payments over forty-two months, beginning August 2013 and maturing January 2017. The outstanding balance of the note as of September 30, 2014 and December 31, 2013 was $65,897 and $85,198, respectively.
	Note Receivable — Related Party
	Effective October 2012, a stockholder and former director of the Company transferred ownership in his clinic to a third party in connection with which the Company assessed a contractual transfer fee of $21,750. We accepted the stockholder’s promissory note in the amount $21,750 in payment of this fee. The note has not been formalized with terms, including interest rate or payment schedules and, accordingly, was presented as a long-term note receivable at December 31, 2013.  Due to uncertainty surrounding the collectability of the note, we reserved the note in full as of September 30, 2014.
	We consider a reserve for doubtful accounts on notes receivable. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is our best estimate of uncollectible amounts and is determined based on specific identification and historical performance we track on an ongoing basis. Losses ultimately could differ materially from amounts estimated in determining the allowance. The allowance for doubtful accounts on notes receivable was $21,750 as of September 30, 2014 and $0 as of December 31, 2013.

Note_3_Property_and_Equipment

Note 3 - Property and Equipment	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 3:     Property and Equipment
	Property and equipment consists of the following:
		September 30,			December 31,
		2014			2013
	Office and computer equipment	$	142,157		$	28,817
	Leasehold improvements		435,748			-
	Software developed		432,330			379,415
			1,010,235			408,232
	Accumulated depreciation and amortization		(238,802	)		(117,047	)
			771,433			291,185
	Assets in progress		22,950			109,082
		$	794,383		$	400,267
	Depreciation and amortization expense was $52,823 and $19,142 for the three months ended September 30, 2014 and 2013, respectively, and $141,707 and $50,656 for the nine months ended September 30, 2014 and 2013, respectively.
	As of September 30, 2014, assets in progress represents new software under development. As of December 31, 2013, assets in progress includes costs for signage, furniture and equipment related to the February 2014 corporate office relocation as well as new software under development. These costs are transferred to the appropriate property and equipment category and commence depreciation when the assets become ready for their intended use.

Note_4_Related_Party_Transacti

Note 4 - Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 4:      Related Party Transactions
	We entered into consulting and legal agreements with certain common stockholders related to services performed for the operations of the Company.  Amounts paid to or for the benefit of these stockholders was approximately $293,150 and $163,600 for the three months ended September 30, 2014 and 2013, respectively, and $670,800 and $487,800 for the nine months ended September 30, 2014 and 2013, respectively.

Note_5_Contingencies

Note 5 - Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 5:      Contingencies
	We are party to litigation in the normal course of business that we do not believe would have a material adverse effect on our business, results of operations or financial condition.

Note_6_Subsequent_Events

Note 6 - Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 6:      Subsequent Events
	The Company completed an initial public offering of its of common stock on November 14, 2014.  See Note 1.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	These unaudited financial statements represent the condensed consolidated financial statements of The Joint Corp. and its wholly owned subsidiary The Joint Corporate Unit No. 1, LLC (collectively, the “Company”). These unaudited condensed consolidated financial statements should be read in conjunction with The Joint Corp. and Subsidiary consolidated financial statements and the notes thereto as set forth in The Joint Corp.’s Form S-1, which included all disclosures required by generally accepted accounting principles. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company on a consolidated basis and the consolidated results of operations and cash flows for the interim periods presented. The results of operations for the periods ended September 30, 2014 and 2013 are not necessarily indicative of expected operating results for the full year. The information presented throughout the document as of and for the periods ended September 30, 2014 and 2013 is unaudited.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk
	We grant credit in the normal course of business to franchisees related to the collection of initial franchise fees, royalties, and other operating revenues. We periodically perform credit analysis and monitor the financial condition of the franchisees to reduce credit risk. As of September 30, 2014 and December 31, 2013, two franchisees represented 31% of outstanding accounts receivable. We did not have any customers that represented greater than 10% of our revenues during the three and nine months ended September 30, 2014 and 2013.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable
	Accounts receivable represent amounts due from franchisees for royalties and marketing and advertising fees and contributions. We consider a reserve for doubtful accounts based on the creditworthiness of our franchisees. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is our best estimate of uncollectible amounts and is determined based on specific identification and historical performance we track on an ongoing basis. Losses could differ materially from amounts estimated in determining the allowance. We determined that an allowance for doubtful accounts was not necessary at December 31, 2013. As of September 30, 2014, we had allowance for doubtful accounts of $70,081.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets
	We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to undiscounted future cash flows in our assessment of whether or not long-lived assets have been impaired. No impairments of long-lived assets were recorded for the periods ended September 30, 2014 and 2013.
Advertising Fund [Policy]	Advertising FundWe have established an advertising fund for national marketing and advertising of services offered by the clinics owned by the franchisees. As stipulated in the typical franchise agreement, a franchisee, in addition to the monthly royalty fee, pays a monthly marketing fee of 1% of gross sales, which may increase to 2% at our discretion. We segregate the marketing funds collected and use the funds for specific purposes as outlined in our franchise disclosure document. As amounts are expended from the fund, we recognize advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on our condensed consolidated balance sheets.
Cooperative Advertising Policy [Policy Text Block]	Co-Op Marketing Funds
	Franchisees have established regional co-ops for advertising within their local and regional markets. The Joint maintains an agency relationship under which the marketing funds collected are segregated and used for the specified purposes as directed by the co-ops officers. The marketing funds are included in restricted cash on our condensed consolidated balance sheets.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	We generate revenue through initial franchise fees, regional developer fees, transfer fees, royalties, IT related income, and computer software fees.
	Initial Franchise Fees. We require the entire non-refundable initial franchise fee to be paid upon execution of the franchise agreement. Initial franchise fees received from a franchisee are recognized as revenue when we have performed substantially all initial services required by the franchise agreement, which generally is considered to be upon the opening of each franchised clinic.  Franchise agreements have an initial term of ten years.  The franchisor’s services under the franchise agreement include: training of franchisee and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees or guarantees on their behalf.
	Regional Developer Fees. During 2011, we established a regional developer program to bring on independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee of 25% of the then current franchise fee for each franchise they receive the right to develop within a specified geographical region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive 50% of franchise fees collected upon the sale of franchises within their region, and a royalty of 3% of sales generated by franchised clinics in their region. Regional developer fees are non-refundable and are recognized as revenue when we have performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Upon the execution of a regional developer agreement, we estimate the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. When we anticipate that the number of franchised clinics to be opened will exceed the contracted minimum, the license fee on a per-clinic basis is determined by dividing the total fee collected from the regional developer by the number of clinics expected to be opened within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. We reassess the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the fee per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the remaining unopened franchised clinics within the region. The franchisor’s services under regional developer agreements include site selection, grand opening support for two clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of our regional developer agreements grant us the option to repurchase the regional developer’s license.
	Royalties.  We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales and a marketing and advertising fee of 1% of gross sales. Certain franchisees with franchise agreements acquired during our formation pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales period has ended. We consider a reserve for doubtful accounts based on the creditworthiness of the franchisee. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that we track on an ongoing basis.
	IT Related Income and Software Fees.  We collect a monthly computer software fee for use of our proprietary chiropractic software, computer support, and internet services support, which was rolled out to all the clinics in April 2012. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase the clinics’ computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue upon receipt of equipment by the franchisee.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs
	Our policy is to expense all operating advertising costs as incurred. Advertising expenses were $53,691 and $104,320 for three months ended September 30, 2014 and 2013, respectively, and $93,730 and $238,529 for the nine months ended September 30, 2014 and 2013, respectively.
Selling, General and Administrative Expenses, Policy [Policy Text Block]	Selling, General and Administrative Costs
	General and administrative costs. General and administrative costs include all corporate and administrative functions that support our clinics and provide an infrastructure to facilitate our operations and future growth. Components of these costs include executive management, supervisory and staff salaries, bonuses and related taxes and employee benefits, marketing, travel, information systems, training, support center rent and related occupancy costs, and professional and consulting fees.
	Selling and marketing expenses. Selling and marketing expenses consist principally of advertising and promotion, outside services, media and advertising, marketing fund expenditures and internal software costs. These costs are directed through our chief marketing officer and are paid for with the 1.0% marketing fee we collect from franchisees. Outside services and costs includes programs to create brand awareness and promotion in new markets for potential clinic locations. All advertising costs are expensed as incurred.
	Depreciation and amortization. Depreciation and amortization is computed using the straight line method over the estimated useful lives of any property and equipment.
Income Tax, Policy [Policy Text Block]	Income Taxes
	We account for income taxes in accordance with the Accounting Standards Codification that requires the recognition of deferred income taxes for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.
	At September 30, 2014 and December 31, 2013, we maintained a liability for income taxes for uncertain tax positions of approximately $204,000 and $148,000, respectively, of which $50,000 and $33,000 respectively, represent penalties and interest and are recorded in the  “other liabilities” section of the accompanying condensed consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Our tax returns for tax years subject to examination by tax authorities include 2011 through the current period for state and federal reporting purposes.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) per Common Share
	Basic earnings (loss) per common share includes no dilution and is computed by dividing the earnings (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options. The impact of all potentially dilutive securities outstanding was anti-dilutive for the three and nine months ended September 30, 2014, as a net loss was incurred for these periods.
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Net income (loss)	$	(202,373	)	$	42,547	$	(464,019	)	$	155,899
	Weighted average common shares outstanding - basic		4,828,122			5,340,000		4,819,861			5,340,000
	Effect of dilutive preferred shares		-			1,335,000		-			1,335,000
	Weighted average common shares outstanding - diluted		4,828,122			6,675,000		4,819,861			6,675,000
	Basic earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.03
	Diluted earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.02
	Securities outstanding at September 30, 2014 which could be dilutive in future periods, some of which are included in the periods presented, include preferred stock convertible into 1,335,000 shares of common stock issued in 2010, options to purchase 534,000 shares of common stock issued in 2013 in connection with the purchase of treasury stock, options to purchase 268,335 shares of common stock and 542,352 shares of unvested restricted stock issued as compensation in 2014.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs and the related deferred tax assets and liabilities as long-term or current, uncertain tax positions and realizability of deferred tax assets.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle, and in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our condensed consolidated financial statements.

Note_1_Nature_of_Operations_an1

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Schedule of Franchisor Disclosure [Table Text Block]		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Clinics open at beginning of period		215			130		175			82
	Clinics opened during the period		16			24		57			74
	Clinics closed during the period		(1	)		-		(2	)		(2	)
	Clinics in operation at the end of the period		230			154		230			154
	Clinics sold but not yet operational							248			254
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014			2013
	Net income (loss)	$	(202,373	)	$	42,547	$	(464,019	)	$	155,899
	Weighted average common shares outstanding - basic		4,828,122			5,340,000		4,819,861			5,340,000
	Effect of dilutive preferred shares		-			1,335,000		-			1,335,000
	Weighted average common shares outstanding - diluted		4,828,122			6,675,000		4,819,861			6,675,000
	Basic earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.03
	Diluted earnings per share	$	(0.04	)	$	0.01	$	(0.10	)	$	0.02

Note_3_Property_and_Equipment_

Note 3 - Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		September 30,			December 31,
		2014			2013
	Office and computer equipment	$	142,157		$	28,817
	Leasehold improvements		435,748			-
	Software developed		432,330			379,415
			1,010,235			408,232
	Accumulated depreciation and amortization		(238,802	)		(117,047	)
			771,433			291,185
	Assets in progress		22,950			109,082
		$	794,383		$	400,267

Note_1_Nature_of_Operations_an2

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended	0 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Nov. 18, 2014	Nov. 14, 2014
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Allowance for Doubtful Accounts Receivable	$70,081		$70,081
Impairment of Long-Lived Assets Held-for-use			0	0
Franchise Monthly Marketing Fee, Gross Sales, Percentage			1.00%
Franchise Agreement, Initial Term			10 years
Regional Developers License Fee, Current Franchise Fee, Percentage			25.00%
Regional Developers Receive, Franchise Fees Collected Upon Sale of Franchise, Percentage			50.00%
Regional Developers Royalty, Sales Generated by Franchises, Percentage			3.00%
Regional Developers, Grand Opening Support, Number of Clinics			2
Franchise Royalty, Gross Sales, Percentage			7.00%
Advertising Expense	53,691	104,320	93,730	238,529
Unrecognized Tax Benefits	204,000		204,000		148,000
Preferred Stock Covnertible Into Common Stock [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			1,335,000
Equity Option Issued in 2013 [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			534,000
Equity Option [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			268,335
Restricted Stock [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			542,352
Earliest Tax Year [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Open Tax Year			2011
Two Franchisees [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Number of Franchises			2		2
Concentration Risk, Percentage			31.00%		31.00%
Subsequent Event [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)							3,000,000
Share Price (in Dollars per share)							$6.50
Proceeds from Issuance Initial Public Offering							17,285,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)						450,000
Proceeds from Stock Options Exercised						2,710,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)						90,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)						$8.13
Scenario, At the Company's Discretion [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Franchise Monthly Marketing Fee, Gross Sales, Percentage			2.00%
Other Noncurrent Liabilities [Member]
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) [Line Items]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$50,000		$50,000		33,000

Note_1_Nature_of_Operations_an3

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) - Franchise Agreements (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Franchise Agreements [Abstract]
Clinics open at beginning of period	215	130	175	82
Clinics opened during the period	16	24	57	74
Clinics closed during the period (in Dollars)	($1)		($2)	($2)
Clinics in operation at the end of the period	230	154	230	154
Clinics sold but not yet operational	248	254	248	254

Note_1_Nature_of_Operations_an4

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details) - Earnings (Loss) Per Common Share (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings (Loss) Per Common Share [Abstract]
Net income (loss) (in Dollars)	($202,373)	$42,547	($464,019)	$155,899
Weighted average common shares outstanding - basic	4,828,122	5,340,000	4,819,861	5,340,000
Effect of dilutive preferred shares		1,335,000		1,335,000
Weighted average common shares outstanding - diluted	4,828,122	6,675,000	4,819,861	6,675,000
Basic earnings per share (in Dollars per share)	($0.04)	$0.01	($0.10)	$0.03
Diluted earnings per share (in Dollars per share)	($0.04)	$0.01	($0.10)	$0.02

Note_2_Notes_Receivable_Detail

Note 2 - Notes Receivable (Details) (USD $)	1 Months Ended
	Jul. 31, 2012	Sep. 30, 2014	Dec. 31, 2013	Oct. 31, 2012
Note 2 - Notes Receivable (Details) [Line Items]
Allowance for Doubtful Accounts Receivable		$70,081
Former Director of the Company [Member]
Note 2 - Notes Receivable (Details) [Line Items]
Due from Related Parties				21,750
Notes Receivable, Related Parties				21,750
Allowance for Doubtful Accounts Receivable		21,750	0
Company-Owned Clinic [Member]
Note 2 - Notes Receivable (Details) [Line Items]
Financing Receivable, Net	$90,000	$65,897	$85,198
Notes Receivable, Interest Rate	6.00%
Notes Receivable Contractual Term	54 months
Notes Receivable Principal and Interest Term	42 months

Note_3_Property_and_Equipment_1

Note 3 - Property and Equipment (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Property, Plant and Equipment [Abstract]
Depreciation, Depletion and Amortization	$52,823	$19,142	$141,707	$50,656

Note_3_Property_and_Equipment_2

Note 3 - Property and Equipment (Details) - Property and Equipment (USD $)	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property and Equipment, Net	$794,383	$400,267
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, Gross	142,157	28,817
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, Gross	435,748
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, Gross	432,330	379,415
Property, Plant and Equipment Excluding Assets in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, Gross	1,010,235	408,232
Accumulated depreciation and amortization	-238,802	-117,047
Property and Equipment, Net	771,433	291,185
Assets in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, Net	$22,950	$109,082

Note_4_Related_Party_Transacti1

Note 4 - Related Party Transactions (Details) (Shareholder [Member], USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Shareholder [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Related Party Transaction, Amounts of Transaction	$293,150	$163,600	$670,800	$487,800